Sir,

We read with great interest, the article on the relationship between glycated hemoglobin (HbA1c), Intensive Care Unit (ICU) admission blood sugar and glucose control with ICU mortality in critically ill patients by Mahmmodpor *et al*.\[[@ref1]\]

The literature on glycemic control in intensive care is taking turns from its earlier publication by van den Berghe done 13 years back, that stress hyperglycemia increases mortality and morbidity. Subsequent studies suggested that intensive glucose control increases hypoglycemic episodes (NICE-SUGAR study),\[[@ref2]\] and recently researchers have stressed the importance of glycemic variability.

This study, again suggests the need for HbA1c in all patients with hyperglycemia presenting to intensive care for the diagnosis of occult diabetes mellitus or stress-induced hyperglycemia (SIH), with SIH associated with more mortality, especially in patients with trauma, as elucidated in previous studies.\[[@ref3][@ref4]\]

We need more clarifications from the authors regarding the study with reference to the points listed below:

The sample size of 500 seems to be arbitrarily chosen a priori, the justification of targeting this sample size is not clear in the methodologyThe targets for blood sugar in septic and nonseptic patients should have been a range rather than a fixed value. We don't think it\'s justified to use an arterial line for the sole purpose of glucose monitoring. The initial sample could have been sent to the central laboratory along with HbA1c, for better accuracy (central laboratory \> arterial blood gas analyzer \> arterial blood sample by glucometer \> venous blood sample by glucometer \> capillary sample by glucometer)\[[@ref5]\]The mortality cannot be attributed to the level of HbA1c alone as the baseline APACHE 2 scores are significantly different. It would have been more informative if they had described the data while grouping the patients between levels of HbA1c\[[@ref4]\]There is limited data given in this study regarding baseline body mass index to interpret the existing paradox in diabetics, patient\'s on corticosteroids (which would have continued in few patients in this study, as the data analysis mentions that 48.4% of patients were on drugs), patient\'s on vasopressors and the details of nutrition.
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